日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype

MET基因改变在肺腺癌脑转移瘤中富集,定义了一种独特的生物学亚型。

Burns, Timothy F; Dacic, Sanja; Chakka, Anish; Miller, Ethan; Velez, Maria A; Somasundaram, Ashwin; Bhattacharya, Saveri; Gaither-Davis, Autumn; Devadassan, Princey; Jin, Jingxiao; Kumar, Vinod; Pennathur, Arjun; Xiu, Joanne; Oberley, Matthew; Glantz, Michael J; Aulakh, Sonikpreet; Chandran, Uma R; Bao, Riyue; Tatsuoka, Curtis; Stabile, Laura P

The Impact of Holder Pasteurization on Macronutrients, Vitamins, Minerals, and Bioactive Factors in Human Milk Processed in a Milk Bank Setting.

母乳库环境下加工的人乳中,巴氏杀菌对宏量营养素、维生素、矿物质和生物活性因子的影响

Davis Autumn, Lee Sheridan, Hampel Daniela, Shahab-Ferdows Setareh, Allen Lindsay H, Bode Lars, Mansen Kimberly, Israel-Ballard Kiersten, Perrin Maryanne T

Impact of Holder Pasteurization and Preanalytical Handling Techniques on Fat Concentration in Donor Human Milk: A Scoping Review

巴氏杀菌法和预分析处理技术对捐赠人乳中脂肪浓度的影响:一项范围界定综述

Davis, Autumn; Perrin, Maryanne T

CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma

CASTOR1磷酸化预示着KRAS突变型肺腺癌男性患者的预后不良

Loo, Suet Kee; Sica, Gabriel; Wang, Xian; Li, Tingting; Chen, Luping; Gaither-Davis, Autumn; Huang, Yufei; Burns, Timothy F; Stabile, Laura P; Gao, Shou-Jiang

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer.

菲克拉妥珠单抗和西妥昔单抗治疗西妥昔单抗耐药、复发/转移性头颈癌的 I 期研究

Bauman Julie E, Ohr James, Gooding William E, Ferris Robert L, Duvvuri Umamaheswar, Kim Seungwon, Johnson Jonas T, Soloff Adam C, Wallweber Gerald, Winslow John, Gaither-Davis Autumn, Grandis Jennifer R, Stabile Laura P

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

白细胞介素-1配体作为西妥昔单抗疗效潜在预测生物标志物的初步分析

Espinosa-Cotton, Madelyn; Fertig, Elana J; Stabile, Laura P; Gaither-Davis, Autumn; Bauman, Julie E; Schmitz, Sandra; Gibson-Corley, Katherine N; Cheng, Yinwen; Jensen, Isaac J; Badovinac, Vladimir P; Laux, Douglas; Simons, Andrean L

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer

一项针对晚期非小细胞肺癌患者的rilotumumab(AMG 102,一种肝细胞生长因子抑制剂)联合厄洛替尼的1/2期研究

Tarhini, Ahmad A; Rafique, Imran; Floros, Theofanis; Tran, Phu; Gooding, William E; Villaruz, Liza C; Burns, Timothy F; Friedland, David M; Petro, Daniel P; Farooqui, Mariya; Gomez-Garcia, Jose; Gaither-Davis, Autumn; Dacic, Sanja; Argiris, Athanassios; Socinski, Mark A; Stabile, Laura P; Siegfried, Jill M

15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers

15q12变异、痰液基因启动子高甲基化与肺癌风险:一项针对吸烟者的全基因组关联研究

Leng, Shuguang; Liu, Yushi; Weissfeld, Joel L; Thomas, Cynthia L; Han, Younghun; Picchi, Maria A; Edlund, Christopher K; Willink, Randall P; Gaither Davis, Autumn L; Do, Kieu C; Nukui, Tomoko; Zhang, Xiequn; Burki, Elizabeth A; Van Den Berg, David; Romkes, Marjorie; Gauderman, W James; Crowell, Richard E; Tesfaigzi, Yohannes; Stidley, Christine A; Amos, Christopher I; Siegfried, Jill M; Gilliland, Frank D; Belinsky, Steven A

Gastrin-releasing peptide receptor expression in non-cancerous bronchial epithelia is associated with lung cancer: a case-control study

非癌性支气管上皮细胞中胃泌素释放肽受体的表达与肺癌相关:一项病例对照研究

Egloff, Ann Marie; Gaither Davis, Autumn; Shuai, Yongli; Land, Stephanie; Pilewski, Joseph M; Luketich, James D; Landreneau, Rodney; Miller, York E; Grandis, Jennifer R; Siegfried, Jill M

Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice.

同时靶向 c-Met 和 EGFR 通路可对转基因小鼠的肺肿瘤发生产生叠加抑制作用

Stabile Laura P, Rothstein Mary E, Keohavong Phouthone, Lenzner Diana, Land Stephanie R, Gaither-Davis Autumn L, Kim K Jin, Kaminski Naftali, Siegfried Jill M